Results 1 to 10 of about 3,249 (159)

Locking Up the AS1411 Aptamer With a Flanking Duplex: Towards an Improved Nucleolin-Targeting

open access: yesPharmaceuticals, 2021
We have designed AS1411-N6, a derivative of the nucleolin (NCL)-binding aptamer AS1411, by adding six nucleotides to the 5′-end that are complementary to nucleotides at the 3′-end forcing it into a stem-loop structure. We evaluated by several biophysical
Carla Cruz   +2 more
exaly   +4 more sources

AS1411-functionalized albumin nanoparticles for nucleolin-targeted realgar delivery and therapy in triple-negative breast cancer [PDF]

open access: yesFrontiers in Pharmacology
Realgar (As4S4) has shown antitumor activity, but its pharmaceutical application is limited by poor aqueous solubility, low bioavailability, and systemic toxicity. In this study, we developed AS1411-functionalized albumin nanoparticles (As4S4@ BSA-AS1411
Liping Dong   +5 more
doaj   +3 more sources

Mechanistic Studies of Anticancer Aptamer AS1411 Reveal a Novel Role for Nucleolin in Regulating Rac1 Activation

open access: yesMolecular Oncology, 2015
AS1411 is a G‐rich quadruplex‐forming oligodeoxynucleotide that binds specifically to nucleolin, a protein found on the surface and in the cytoplasm of most malignant cells but absent from the surface/cytoplasm of most normal cells.
Matthew K Forsthoefel
exaly   +3 more sources

AS1411-Induced Lipidomic Alterations and Therapeutic Insights in U-87 Glioblastoma Cells [PDF]

open access: yesBiomolecules
Glioblastoma (GBM) is a devastating brain tumor heavily reliant on metabolic reprogramming for survival. The DNA aptamer AS1411 specifically targets cell-surface nucleolin (NCL), a protein overexpressed in GBM; however, its precise metabolic consequences
Ozan Kılıçkaya, Serap Şahin
doaj   +3 more sources

Anti-Nucleolin Aptamer AS1411: An Advancing Therapeutic

open access: yesFrontiers in Molecular Biosciences, 2023
Targeted therapy is highly desirable, as it allows for selective cytotoxicity on diseased cells without off-target side effects. Nucleolin is a remarkable target for cancer therapy given its high abundance, selective presence on the plasma membrane, and ...
Alexander Van den Avont   +1 more
exaly   +3 more sources

Insights Into the Binding Mode of AS1411 Aptamer to Nucleolin

open access: yesFrontiers in Molecular Biosciences, 2022
AS1411 aptamer can function as a recognition probe to detect the cell surface nucleolin overexpressed in cancer cells, however, little is known about their binding process.
Lianjun Zhang, Jiang Fuze
exaly   +3 more sources

A target-activated AS1411 aptamer probe for in vivo and ex vivo imaging of nucleolin-overexpressing triple-negative breast cancer [PDF]

open access: yesFrontiers in Bioengineering and Biotechnology
BackgroundFluorescence imaging of breast cancer is often limited by high background signals from conventional “always-on” probes. The nucleolin-targeting AS1411 aptamer provides a promising recognition element for tumors with elevated nucleolin ...
Juntao Tan   +7 more
doaj   +2 more sources

Extracellular Vesicle‐Mediated Nucleolin Transfer in Glioblastoma: A Targetable Axis Driving Blood‐Tumour Barrier Formation [PDF]

open access: yesJournal of Extracellular Vesicles
Glioblastoma (GBM) remains a significant therapeutic challenge. While GBM‐derived extracellular vesicles (EVs) are known to remodel the normal blood‐brain barrier (BBB) into a blood‐tumour barrier (BTB), the underlying mechanism is largely not understood.
Hongzhen Chen   +7 more
doaj   +2 more sources

Aptamer-engineered NIR-II Ru-doped carbon quantum dot nanozyme for photoacoustic imaging-guided synergistic photothermal and catalytic cancer therapy [PDF]

open access: yesJournal of Nanobiotechnology
Carbon quantum dot (CQD)-based nanozymes have attracted growing interest for advanced biomedical applications owing to their superior catalytic activity, photostability, and biocompatibility. However, the rational design of a multifunctional nanoplatform
Yumin Hao   +8 more
doaj   +2 more sources

AS1411-Bivalent-Cholesterol-Anchor Equipped with Zinc Phthalocya-Nine Enables NK Cells Derived Exosomes to Realize Effective Tumor-Tropism Photodynamic Therapy [PDF]

open access: yesPharmaceutics
Background/Objectives: Benefiting from their outstanding tumor-penetrating ability and cytotoxic proteins and cytokines, natural-killer-cell-derived exosomes (NEX) show great potential for cell-free tumor immunotherapy.
Yuchen Qi   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy